Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on January 25, 2013, regarding an event dated January 22, 2013. The filing addresses corporate governance changes specifically related to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change disclosed is the departure of a director. R. Sanders Williams, M.D., notified the company that he will not stand for re-election to the Board of Directors at the 2013 Annual Meeting of Stockholders, expected to be held in May 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific departure of the director.
Key Facts for Investor Verification
- R. Sanders Williams, M.D., will not seek re-election to the Board of Directors.
- The 2013 Annual Meeting of Stockholders is expected to occur in May 2013.
- No financial data or operational metrics are included in this specific filing.